Nu-Med Plus (NUMD) Profit After Tax Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) Profit After Tax Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.96% |
| Sep 30, 2025 | 51.67% |
| Jun 30, 2025 | 58.15% |
| Mar 31, 2025 | 33.51% |
| Dec 31, 2024 | 45.01% |
| Sep 30, 2024 | 34.13% |
| Jun 30, 2024 | 41.31% |
| Mar 31, 2024 | 44.86% |
| Dec 31, 2023 | 30.17% |
| Sep 30, 2023 | 50.04% |
| Jun 30, 2023 | 32.50% |
| Mar 31, 2023 | 28.17% |
| Dec 31, 2022 | 17.91% |
| Sep 30, 2022 | 16.50% |
| Jun 30, 2022 | 12.93% |
| Mar 31, 2022 | -15.03% |
| Dec 31, 2021 | 18.86% |
| Sep 30, 2021 | 31.28% |
| Jun 30, 2021 | -1.25% |
| Mar 31, 2021 | -15.24% |